Literature DB >> 19524297

Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgene.

Christelle Vincent-Fabert, Rémi Fiancette, Véronique Truffinet, Nadine Cogné, Michel Cogné, Yves Denizot.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19524297     DOI： 10.1016/j.leukres.2009.05.018

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Targeting the oncogene B lymphoma deregulator IgH 3' regulatory region does not impede the in vivo inflammatory response in mice.

Authors:  Faten Saad; Alexis Saintamand; Pauline Rouaud; Yves Denizot
Journal:  Oncoscience       Date:  2014-09-19

Review 2.  The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.

Authors:  Nour Ghazzaui; Alexis Saintamand; Hussein Issaoui; Christelle Vincent-Fabert; Yves Denizot
Journal:  Oncotarget       Date:  2017-01-24

Review 3.  Mouse Models of c-myc Deregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis.

Authors:  Melissa Ferrad; Nour Ghazzaui; Hussein Issaoui; Jeanne Cook-Moreau; Yves Denizot
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.